New cancer drug enters first human trials for Tough-to-Treat tumors
Disease control
Recruiting now
This is an early-stage study to test the safety and find the right dose of a new investigational drug called IMGS-001. It is for adults with advanced solid tumors that have come back or stopped responding to standard treatments. The study will first test several doses for safety …
Phase: PHASE1 • Sponsor: ImmunoGenesis • Aim: Disease control
Last updated Apr 01, 2026 21:41 UTC